Filing Flows › Cardiff Oncology (CRDF) › Q2 2026 › vs Q2 2025
Cardiff Oncology (CRDF) Q2 2026 vs Q2 2025 (year over year)
Cardiff Oncology's revenue fell $17K (-14%) from $121K in Q2 2025 to $104K in Q2 2026.
Cardiff Oncology, Q2 2026: revenue $104K (-14% year over year), net loss $9.2M, operating cash flow −$11.8M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $104K | $121K | −$17K | -14% |
| Other income, net | $383K | $834K | −$451K | -54% |
| Net loss | $9.2M | $13.9M | −$4.7M | -34% |
| Costs & expenses | $9.7M | $14.9M | −$5.2M | -35% |
| Operating costs | $9.7M | $14.9M | −$5.2M | -35% |
| Research & development | $5.9M | $11.6M | −$5.7M | -49% |
| SG&A | $3.8M | $3.3M | $486K | +15% |
| Operating cash sources | $12.8M | $10.1M | $2.7M | +26% |
| Depreciation | $87K | $94K | −$7K | -7% |
| Share-based compensation | $920K | $1.7M | −$763K | -45% |
| Cash used in operations | $11.8M | $8.3M | $3.4M | +41% |
| Net loss absorbed | $9.2M | $13.9M | −$4.7M | -34% |
| Working capital & other | $3.5M | −$3.8M | $7.4M | — |
Questions
How much did Cardiff Oncology's revenue grow year over year in Q2 2026?
Cardiff Oncology's revenue fell $17K (-14%) from $121K in Q2 2025 to $104K in Q2 2026.